SYSTEMATIC REVIEW ON THE PSYCHOMETRIC, RELIABILITY AND VALIDITY PROPERTIES OF TRANSLATED NEUROPATHIC PAIN SCREENING TOOLS (DN4, LANSS AND PDQ) 1 JANUARY 2005 – 19 JULY 2019
DOI:
https://doi.org/10.11603/ijmmr.2413-6077.2021.1.12120Keywords:
neuropathic pain, positive likelihood, negative likelihood, positive predictive value, negative predictive valueAbstract
Background. Different neuropathic pain screening tools (DN4, LANSS and PDQ) have been developed, translated into several local languages, and validated. To determine the reliability of these tools and their ability to differentiate between diagnosing neuropathic pain quality from nociceptive pain, a systematic review was conducted to synchronize properties and suggest the reliability of the translated version of these neuropathic pain-screening tools.
Objective. To conduct an evidence-based systematic review to assess the psychometric, reliability and validity of the translated version of DN4, LANSS and PDQ between January 2005 and 2019.
Methods. Two independent reviewers adopted the use of online (Internet) search machine (Pubmed, Scopus and Web of science) to search for the relevant articles based on JBI (Joanna Briggs Institute) inclusion criteria. Data extracted from the articles were synthesis in tabular form.
Results. Twenty-six articles were included from DN4 (n=11), LANSS (n=8) and PDQ (n=4) translated from English language to eight local languages. The sensitivity and specificity of the DN4 studies ranged from 75% to 98% and 37.3% to 96%, respectively. The internal reliability (α) of the translated version of the DN4 ranged from 0.55-0.862. The sensitivity and specificity of the LANSS studies ranged from 75% to 98% and 37.3% to 96%, respectively. The internal reliability (α) of the translated version of the LANSS ranged 0.67-0.96. The sensitivity and specificity of the PDQ studies ranged from 75% to 98% and 37.3% to 96%, respectively. The internal reliability (α) of the translated version of the PDQ ranged 0.81-0.86.
Conclusions. All the translated instruments reviewed showed good internal consistency of the items, high sensitivity and Positive predictive value (PPV) but not to a suitable level compared with the original version. Therefore, these screening tools are suggested to be used in conjunction with the clinical testing for appropriate diagnosis of patients with neuropathic pain quality.
References
Scholz J, Finnerup NB, Attal N, Aziz Q, Baron R, Bennett MI, Benoliel R, Cohen M, Cruccu G, Davis KD, Evers S. The IASP classification of chronic pain for ICD-11: chronic neuropathic pain. Pain. 2019 Jan; 160(1):53.
DOI: 10.1097/j.pain.0000000000001365
Colloca L, Ludman T, Bouhassira D, Baron R, Dickenson AH, Yarnitsky D, Freeman R, Truini A, Attal N, Finnerup NB, Eccleston C. Neuropathic pain. Nature reviews Disease primers. 2017 Feb 16;3(1):1-9.
DOI: 10.1038/nrdp.2017.2
Reinhart L, Knight W, Roberts L, Mendes C. HHS public access global burden of disease study 2010. Lancet. 2012;380(9859):2163-96.
DOI: 10.1016/S0140-6736(12)61729-2.
Torta R, Ieraci V, Zizzi F. A review of the emotional aspects of neuropathic pain: from comorbidity to co-pathogenesis. Pain and therapy. 2017 Dec;6(1):11-7.
DOI: 10.1007/s40122-017-0088-z
Rienstra W, Blikman T, Dijkstra B, van Raay J, Slager G, Bulstra S, Stevens M, van den Akker-Scheek I. Validity of the Dutch modified painDETECT questionnaire for patients with hip or knee osteoarthritis. Disability and rehabilitation. 2019 Apr 10;41(8):941-7.
DOI: 10.1080/09638288.2017.1413429
Dueñas M, Ojeda B, Salazar A, Mico JA, Failde I. A review of chronic pain impact on patients, their social environment and the health care system. Journal of pain research. 2016;9:457.
DOI: 10.2147/JPR.S105892
Costigan M, Scholz J, Woolf CJ. Neuropathic pain: a maladaptive response of the nervous system to damage. Annual review of neuroscience. 2009 Jul 21;32:1-32.
DOI: 10.1146/annurev.neuro.051508. 135531
Mathieson S, Maher CG, Terwee CB, De Campos TF, Lin CW. Neuropathic pain screening questionnaires have limited measurement properties. A systematic review. Journal of clinical epidemiology. 2015 Aug 1;68(8):957-66.
DOI: 10.1016/j.jclinepi.2015.03.010
Bennett M. The LANSS Pain Scale: the Leeds assessment of neuropathic symptoms and signs. Pain. 2001 May 1;92(1-2):147-57.
DOI: 10.1016/s0304-3959(00)00482-6
Krause SJ, Backonja MM. Development of a neuropathic pain questionnaire. The Clinical journal of pain. 2003 Sep 1;19(5):306-14.
DOI: 10.1097/00002508-200309000-00004
Bouhassira D, Attal N, Alchaar H, Boureau F, Brochet B, Bruxelle J, Cunin G, Fermanian J, Ginies P, Grun-Overdyking A, Jafari-Schluep H. Comparison of pain syndromes associated with nervous or somatic lesions and development of a new neuropathic pain diagnostic questionnaire (DN4). pain. 2005 Mar 1;114(1-2):29-36.
DOI: 10.1016/j.pain.2004.12.010
Portenoy R, ID Pain Steering Committee. Development and testing of a neuropathic pain screening questionnaire: ID Pain. Current medical research and opinion. 2006 Aug 1;22(8):1555-65.
DOI: 10.1185/030079906X115702
Freynhagen R, Baron R, Gockel U, Tölle TR. Pain DETECT: a new screening questionnaire to identify neuropathic components in patients with back pain. Current medical research and opinion. 2006 Oct 1;22(10):1911-20.
DOI: 10.1185/030079906X132488
Unal-Cevik I, Sarioglu-Ay S, Evcik D. A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the Turkish version of DN4. The Journal of Pain. 2010 Nov 1;11(11):1129-35.
DOI: 10.1016/j.jpain.2010.02.003.
Gudala K, Ghai B, Bansal D. Neuropathic Pain Assessment with the Pain DETECT Questionnaire: Cross-Cultural Adaptation and Psychometric Evaluation to Hindi. Pain Practice. 2017 Nov;17(8):1042-9.
DOI: 10.1111/papr.12562
Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Systematic reviews. 2015 Dec;4(1):1-9.
DOI: 10.1186/2046-4053-4-1
Chatila N, Pereira B, Maarrawi J, Dallel R. Validation of a new Arabic version of the neuropathic pain diagnostic questionnaire (DN4). Pain Practice. 2017 Jan;17(1):78-87.
DOI: 10.1111/papr.12419
Matsuki Y, Sukenaga N, Miyagi K, Tsunetoh T, Mizogami M, Shigemi K, Maeda L, Hirose M. Reliability and validity of the Japanese translation of the DN4 Diagnostic Questionnaire in patients with neuropathic pain. Journal of anesthesia. 2018 Jun;32(3):403-8.
DOI: 10.1007/s00540-018-2495-7
Kim H-J, Park J-H, Bouhassira D, Shin J-H, Chang B-S, Lee C-K, Baek CH, Yeom JS. Validation of the Korean version of the DN4 diagnostic questionnaire for neuropathic pain in patients with lumbar or lumbar-radicular pain. Yonsei medical journal. 2016;57(2):449.
DOI: 10.3349/ymj.2016.57.2.449
Park C, Lee YW, Yoon DM, Kim DH. Cross-cultural adaptation and linguistic validation of the Korean version of the Leeds assessment of neuropathic symptoms and signs pain scale. Journal of Korean medical science. 2015 Sep 1;30(9):1334-9.
DOI: 10.3346/jkms.2015.30.9.1334
Terkawi AS, Backonja MM, Abolkhair A, Almaharbi S, Joy J, Foula F, Alswiti M, Terkawi YS, Al-Zhahrani T, Alghamdi FS, Tsang S. Development and validation of Arabic version of the Neuropathic Pain Questionnaire-short form. Saudi journal of anaesthesia. 2017 May;11(Suppl 1):S53.
DOI: 10.4103/sja.SJA_86_17.
Madani SP, Fateh HR, Forogh B, Fereshtehnejad SM, Ahadi T, Ghaboussi P, Bouhassira D, Raissi GR. Validity and reliability of the persian (farsi) version of the DN 4 (douleur neuropathique 4 questions) questionnaire for differential diagnosis of neuropathic from non-neuropathic pains. Pain Practice. 2014 Jun;14(5):427-36.
DOI: 10.1111/papr.12088
Sykioti P, Zis P, Vadalouca A, Siafaka I, Argyra E, Bouhassira D, Stavropoulou E, Karandreas N. Validation of the Greek Version of the DN 4 Diagnostic Questionnaire for Neuropathic Pain. Pain Practice. 2015 Sep;15(7):627-32.
DOI: 10.1111/papr.12221
Hamdan A, Luna JD, Del Pozo E, Galvez R. Diagnostic accuracy of two questionnaires for the detection of neuropathic pain in the S panish population. European journal of pain. 2014 Jan;18(1):101-9.
DOI: 10.1002/j.1532-2149.2013.00350.x
Perez C, Galvez R, Huelbes S, Insausti J, Bouhassira D, Diaz S, Rejas J. Validity and reliability of the Spanish version of the DN4 (Douleur Neuropathique 4 questions) questionnaire for differential diagnosis of pain syndromes associated to a neuropathic or somatic component. Health and quality of life outcomes. 2007 Dec;5(1):1-0.
DOI: 10.1186/1477-7525-5-66
Santos JG, Brito JO, de Andrade DC, Kaziyama VM, Ferreira KA, Souza I, Teixeira MJ, Bouhassira D, Baptista AF. Translation to Portuguese and validation of the Douleur Neuropathique 4 questionnaire. The Journal of Pain. 2010 May 1;11(5):484-90.
DOI: 10.1016/j.jpain.2009.09.014
Spallone V, Morganti R, D’amato C, Greco C, Cacciotti L, Marfia GA. Validation of DN4 as a screening tool for neuropathic pain in painful diabetic polyneuropathy. Diabetic Medicine. 2012 May;29(5):578-85.
DOI: 10.1111/j.1464-5491.2011.03500.x
Batistaki, C., Lyrakos, G., Drachtidi, K., Stamatiou, G., Kitsou, M.C. and Kostopanagiotou, G., 2016. Translation, Cultural Adaptation, and Validation of Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) and Self-Complete Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) Questionnaires into the Greek Language. Pain Practice, 16(5), pp.552-564.
DOI: 10.1111/papr.12300
Barbosa M, Bennett MI, Verissimo R, Carvalho D. Cross-Cultural Psychometric Assessment of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) Pain Scale in the Portuguese Population. Pain Practice. 2014;14(7):620-4.
DOI: 10.1111/papr.12118
Spanos K, Lachanas VA, Chan P, Bargiota A, Giannoukas AD. Validation of the Leeds Assessment of Neuropathic Symptoms and Signs (LANSS) questionnaire and its correlation with visual analog pain scales in Greek population. Journal of Diabetes and its Complications. 2015 Nov 1;29(8):1142-5.
DOI: 10.1016/j.jdiacomp.2015.08.008
Schestatsky P, Félix-Torres V, Fagundes Chaves ML, Câmara-Ehlers B, Mucenic T, Caumo W, Nascimento O, Bennett MI. Brazilian Portuguese validation of the Leeds Assessment of Neuropathic Symptoms and Signs for patients with chronic pain. Pain Medicine. 2011 Oct 1;12(10):1544-50.
DOI: 10.1111/j.1526-4637.2011.01221.x
Türkel Y, Türker H, Demir IA, Bayrak AO, Onar MK. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey. Adv Clin Exp Med. 2014;23(4):599-603.
DOI: 10.17219/acem/37233
Türkel Y, Türker H, Demir İA, Bayrak AO, Onar MK. Validation of self report version of the Leeds Assessment of Neuropathic Symptoms and Signs score for identification of neuropathic pain in patients from northern Turkey. Adv Clin Exp Med. 2014 Jul 1;23(4):599-603.
DOI: 10.17219/acem/37233
Alkan H, Ardic F, Erdogan C, Sahin F, Sarsan A, Findikoglu G. Turkish version of the painDETECT questionnaire in the assessment of neuropathic pain: a validity and reliability study. Pain Medicine. 2013 Dec 1;14(12):1933-43.
DOI: 10.1111/pme.12222
De Andrés J, Pérez-Cajaraville J, Lopez-Alarcón MD, López-Millán JM, Margarit C, Rodrigo-Royo MD, Franco-Gay ML, Abejón D, Ruiz MA, López-Gomez V. Cultural adaptation and validation of the painDETECT scale into Spanish. The Clinical journal of pain. 2012;28(3):243-53.
DOI: 10.1097/AJP.0b013e31822bb35b
Matsubayashi Y, Takeshita K, Sumitani M, Oshima Y, Tonosu J, Kato S, Ohya J, Oichi T, Okamoto N, Tanaka S. Validity and reliability of the Japanese version of the painDETECT questionnaire: a multicenter observational study. PLoS One. 2013 Sep 30;8(9):e68013.
DOI: 10.1371/journal.pone.0068013
Koc R, Erdemoglu AK. Validity and reliability of the Turkish Self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) questionnaire. Pain Medicine. 2010 Jul 1;11(7):1107-14.
DOI: 10.1111/j.1526-4637.2010.00837.x
López-de-Uralde-Villanueva I, Gil-Martínez A, Candelas-Fernández P, de Andrés-Ares J, Beltrán-Alacreu H, La Touche R. Validity and reliability of the Spanish-language version of the self-administered Leeds Assessment of Neuropathic Symptoms and Signs (S-LANSS) pain scale. Neurología (English Edition). 2018 Oct 1;33(8):505-14.
DOI: 10.1016/j.nrl.2016.10.009
Tsang S, Royse CF, Terkawi AS. Guidelines for developing, translating, and validating a questionnaire in perioperative and pain medicine. Saudi journal of anaesthesia. 2017;11(Suppl 1):S80.
DOI: 10.4103/sja.SJA_203_17
Kuder GF, Richardson MW. The theory of the estimation of test reliability. Psychometrika. 1937 Sep;2(3):151-60.
DOI: 10.1007/BF02288391
Bennett MI, Smith BH, Torrance N, Potter J. The S-LANSS score for identifying pain of predominantly neuropathic origin: validation for use in clinical and postal research. The Journal of Pain. 2005 Mar 1;6(3):149-58.
DOI: 10.1016/j.jpain.2004.11.007
Taber KS. The use of Cronbach’s alpha when developing and reporting research instruments in science education. Research in science education. 2018 Dec;48(6):1273-96.
DOI: 10.1007/s11165-016-9602-2
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 International Journal of Medicine and Medical Research

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Authors who sent their manuscript to International Journal of Medicine and Medical Research agree to the following terms:
1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License CC-BY-NC that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
2. Authors able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).
